FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987573996> ?p ?o ?g. }

• W2987573996 endingPage "248" @default.
• W2987573996 startingPage "238" @default.
• W2987573996 abstract "ObjectiveWe aimed to assess the efficacy and benefit-risk profile of pregabalin (PGN) to reduce the clinical signs of central neuropathic pain (CNeP) as reflected by scratching episodes in dogs with symptomatic syringomyelia (SM).Study designRandomized, double-blind, placebo-controlled crossover study.AnimalsA total of 12 client-owned Cavalier King Charles Spaniels (age, 1.1–7.4 years, bodyweight, 8.2–10.8 kg) with magnetic resonance imaging-confirmed SM and clinical signs of CNeP.MethodsDogs were randomized to either PGN 150 mg or placebo for 25 days, followed by 48 hour washout period before crossover to the alternate phase of 25 days. The primary outcome was defined as number of scratching events during 10 minutes of video-recorded physical activity. Treatment effect was estimated using a generalized estimation equation model. Benefit-risk and quality of life assessments were obtained through owner interviews focusing on potential adverse events.ResultsThe treatment effect estimate was an 84% (95% confidence interval = 75–89%) reduction in mean number of scratching events relative to baseline compared with placebo (p < 0.0001). Owner-assessed satisfactory quality of life was status quo and rated as ‘good’ or ‘could not be better’ in six/11 dogs and improved in four/11 dogs. The most prevalent adverse events were increased appetite in nine/12 dogs and transient ataxia in nine/12 dogs. There was one dog withdrawn by the owner 7 days after crossover to PGN owing to persistent ataxia. No dogs needed rescue analgesia during the trial.Conclusions and clinical relevancePGN is superior to placebo in the reduction of clinical signs of SM-related CNeP in dogs. At a dose range of 13–19 mg kg–1 orally twice daily, the encountered adverse events were acceptable to all but one owner." @default.
• W2987573996 created "2019-11-22" @default.
• W2987573996 creator A5007631249 @default.
• W2987573996 creator A5020701133 @default.
• W2987573996 creator A5024996945 @default.
• W2987573996 creator A5079004219 @default.
• W2987573996 creator A5084914712 @default.
• W2987573996 date "2020-03-01" @default.
• W2987573996 modified "2023-09-26" @default.
• W2987573996 title "Pregabalin alleviates clinical signs of syringomyelia-related central neuropathic pain in Cavalier King Charles Spaniel dogs: a randomized controlled trial" @default.
• W2987573996 cites W158994367 @default.
• W2987573996 cites W1941436389 @default.
• W2987573996 cites W1965621046 @default.
• W2987573996 cites W1977979760 @default.
• W2987573996 cites W1978136073 @default.
• W2987573996 cites W1995284583 @default.
• W2987573996 cites W2022329984 @default.
• W2987573996 cites W2031667116 @default.
• W2987573996 cites W2033166306 @default.
• W2987573996 cites W2040077351 @default.
• W2987573996 cites W2040697501 @default.
• W2987573996 cites W2043710163 @default.
• W2987573996 cites W2058457307 @default.
• W2987573996 cites W2080477042 @default.
• W2987573996 cites W2092472739 @default.
• W2987573996 cites W2096234674 @default.
• W2987573996 cites W2100789060 @default.
• W2987573996 cites W2104818454 @default.
• W2987573996 cites W2128412489 @default.
• W2987573996 cites W2138606636 @default.
• W2987573996 cites W2142711575 @default.
• W2987573996 cites W2145360027 @default.
• W2987573996 cites W2149174813 @default.
• W2987573996 cites W2149856489 @default.
• W2987573996 cites W2149860264 @default.
• W2987573996 cites W2153337753 @default.
• W2987573996 cites W2156174993 @default.
• W2987573996 cites W2161313329 @default.
• W2987573996 cites W2288436510 @default.
• W2987573996 cites W2339279963 @default.
• W2987573996 cites W2410279507 @default.
• W2987573996 cites W2506078057 @default.
• W2987573996 cites W2766114294 @default.
• W2987573996 cites W2794111634 @default.
• W2987573996 cites W2794850243 @default.
• W2987573996 cites W2914288724 @default.
• W2987573996 doi "https://doi.org/10.1016/j.vaa.2019.09.007" @default.
• W2987573996 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32005620" @default.
• W2987573996 hasPublicationYear "2020" @default.
• W2987573996 type Work @default.
• W2987573996 sameAs 2987573996 @default.
• W2987573996 citedByCount "7" @default.
• W2987573996 countsByYear W29875739962020 @default.
• W2987573996 countsByYear W29875739962021 @default.
• W2987573996 countsByYear W29875739962022 @default.
• W2987573996 countsByYear W29875739962023 @default.
• W2987573996 crossrefType "journal-article" @default.
• W2987573996 hasAuthorship W2987573996A5007631249 @default.
• W2987573996 hasAuthorship W2987573996A5020701133 @default.
• W2987573996 hasAuthorship W2987573996A5024996945 @default.
• W2987573996 hasAuthorship W2987573996A5079004219 @default.
• W2987573996 hasAuthorship W2987573996A5084914712 @default.
• W2987573996 hasBestOaLocation W29875739961 @default.
• W2987573996 hasConcept C126322002 @default.
• W2987573996 hasConcept C141071460 @default.
• W2987573996 hasConcept C142724271 @default.
• W2987573996 hasConcept C15490471 @default.
• W2987573996 hasConcept C168563851 @default.
• W2987573996 hasConcept C170493617 @default.
• W2987573996 hasConcept C197934379 @default.
• W2987573996 hasConcept C204787440 @default.
• W2987573996 hasConcept C27081682 @default.
• W2987573996 hasConcept C2776468701 @default.
• W2987573996 hasConcept C2777883359 @default.
• W2987573996 hasConcept C2779245659 @default.
• W2987573996 hasConcept C42219234 @default.
• W2987573996 hasConcept C71924100 @default.
• W2987573996 hasConcept C87813604 @default.
• W2987573996 hasConceptScore W2987573996C126322002 @default.
• W2987573996 hasConceptScore W2987573996C141071460 @default.
• W2987573996 hasConceptScore W2987573996C142724271 @default.
• W2987573996 hasConceptScore W2987573996C15490471 @default.
• W2987573996 hasConceptScore W2987573996C168563851 @default.
• W2987573996 hasConceptScore W2987573996C170493617 @default.
• W2987573996 hasConceptScore W2987573996C197934379 @default.
• W2987573996 hasConceptScore W2987573996C204787440 @default.
• W2987573996 hasConceptScore W2987573996C27081682 @default.
• W2987573996 hasConceptScore W2987573996C2776468701 @default.
• W2987573996 hasConceptScore W2987573996C2777883359 @default.
• W2987573996 hasConceptScore W2987573996C2779245659 @default.
• W2987573996 hasConceptScore W2987573996C42219234 @default.
• W2987573996 hasConceptScore W2987573996C71924100 @default.
• W2987573996 hasConceptScore W2987573996C87813604 @default.
• W2987573996 hasFunder F4320320945 @default.
• W2987573996 hasIssue "2" @default.
• W2987573996 hasLocation W29875739961 @default.
• W2987573996 hasLocation W29875739962 @default.
• W2987573996 hasOpenAccess W2987573996 @default.

• next